Allan B. Massie

Trends in GLP ‐1 Receptor Agonist Prescribing Without an Apparent FDA ‐Approved Indication

ABSTRACT Objective This study evaluated temporal trends and patient characteristics associated with glucagon‐like peptide‐1 (GLP‐1) receptor agonist prescribing among US adults without an apparent FDA‐approved indication. Methods This retrospective cohort study used Cosmos electr...

Early Changes in Kidney Transplantation following Implementation of the Increasing Organ Transplant Access Model

Background: The Increasing Organ Transplant Access (IOTA) model is a mandatory experimental payment model that aims to improve kidney transplant access using financial incentives and penalties for transplant centers randomized to model participation, based primarily on growth in...

Trends in GLP-1 Receptor Agonist Prescriptions for Children Ages 8 to 11 With Obesity: 2019–2026

BACKGROUND AND OBJECTIVES: Clinical practice guidelines for pediatric obesity management allow for consideration of glucagon-like peptide-1 receptor agonists (GLP-1RA) in children ages 8-11. No study has documented secular trends in GLP-1RA prescribing in this group. We hypothesi...